No Detail Found!

Interleukin-10 as a Marker of Disease Progression in Dengue Hemorrhagic Fever.

Author(s)
Ambreen Tauseef Department of Physiology, CMH, Lahore Medical and Dental College, Lahore, Pakistan
Naima Umar Department of Physiology, Fatima Memorial College of Medicine and Dentistry, Lahore, Pakistan
Sana Sabir Department of Physiology, Khawaja Muhammad Safdar Medical College, Sialkot, Pakistan
Ayesha Akmal Department of Physiology, CMH, Lahore Medical and Dental College, Lahore, Pakistan
Saadia Sajjad Department of Physiology, Azra Naheed Medical College, Lahore, Pakistan
Sibgha Zulfiqar Department of Physiology, Shaikh Zayed PGMI, Lahore, Pakistan
Abstract
Objective: To evaluate the plasma interleukin-10 (IL-10) levels in patients suffering from dengue hemorrhagic fever between 4 to 7 days of onset of disease and 24 hours after the first sample, to find out the association of plasma IL-10 levels with the outcome. Study Design: Analytical study. Place and Duration of Study: All major hospitals of Lahore, Pakistan, from August to November 2012. Methodology: Participants included 50 registered patients of dengue hemorrhagic fever (DHF) aged between 15 - 50 years. Plasma IL-10 concentrations were measured on above stated day. Outcome was described as recovery and shock. Platelet count and hematocrit percentages were also recorded. Statistical analyses were done using SPSS version 19. A p-value = 0.05 was considered significant. Results: Plasma IL-10 levels were found to be raised in DHF patients and were associated with fatal outcome (p=0.004). In recovered DHF patients, plasma IL-10 levels decreased after 24 hours (mean 26.54 ±16.03 pg/ml) as compared to admission time (mean 74.39 ±61.69 pg/ml) but in case of DHF patients suffering from shock, plasma IL-10 was found to be higher after 24 hours (mean 87.69 ±7.77 pg/ml) as compared to levels at admission time (mean 42.56 ±28.09 pg/ml). ROC curve analysis revealed a change (30 units pg/ml) of plasma IL-10 concentration, within 24 hours of admission, raised from the base line to be 105 times more critical for shock in DHF patients (100% sensitivity and 71.4% specificity, p < 0.001). Conclusion: Elevated plasma IL-10 is a potential predictor of disease severity and fatal outcome in DHF patients.
Publication Details
Page(s) 187-190
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 26, Issue: 3, Year: 2016

Request the full text from PASTIC

References
GublerDJ, 2002.Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century,Trends Microbiol 10 100 -3
.,Accessed on 8/10/15 -
HalsteadSB, 2007.,Dengue. Lancet 370 1644 -52
RiazMM,MumtazK,KhanMS,PatelJ,TariqM,HilalH, 2009.a clinical perspective,J Pak Med Assoc 59 339 -44
ChaturvediUC,NagarR, 2009.Nitric oxide in dengue and dengue hemorrhagic fever: necessity or nuisance?,FEMS Immunol Med Microbiol 9 -24
SrikiatkhachornA,GreenS., 2010.Markers of dengue disease severity,Curr Top Microbiol Immunol 338 67 -82
MangadaMM,RothmanAL, 2005.Altered cytokine responses of dengue-specific CD4+ T-cells to heterologous serotypes,J immunol 175 2676 -83
TangY,KouZ,ZhangF,YaoX,LiuS, 2010.Both viremia and cytokine levels associate with the lack of severe disease in secondary dengue1 infection among adult Chinese patients,PLoS one 5 1 -8
TsaiTT,ChuangYJ,LinYS,WanSW,ChenCL,LinCF, 2013.An emerging role for the anti-inflammatory cytokine interleukin-10 in dengue virus infection,J Biomed Sci 20 40 -
MalavigeGN,FernandoN,OggG, 2011.Pathogenesis of dengue viral infections,Sri Lankan J Infect Dis 1 2 -8
BozzaFA,CruzOG,ZagneS,AzeredoEL,NogueiraR,AssisEF, 2008.Multiple cytokine profile from dengue patients: MIP-l beta and IFN-gamma as predictive factors for severity,BMC Infect Dis 8 86 -
FangX,HuZ,ShangW,ZhuJ,XuC,RaoX, 2012.Genetic polymorphisms of molecules involved in host immune response to dengue virus infection,FEMS Immunol Med Microbiol 66 134 -46
AsadullahK,SterryW,VolkHD, 2003.Interleukin-10 therapy-review of a new approach,Pharm Rev 55 2241 -69
GreenS,RothmanA, 2006.Immunopathological mechanism in dengue and dengue hemorrhagic fever,Curr Opin Infect Dis 19 429 -36
MalavigeGN,FernandoS,FernandoDJ,SeneviratneSL, 2004.Dengue viral infections,Postgrad Med J 80 588 -601
NguyenTH,LeiHY,NguyenTL,LinYS,HuangKJ,LeBL, 2004.Dengue hemorrhagic fever in infants: A study of clinical and cytokine profiles,J Infect Dis 189 221 -32
GurugamaP,GargP,PereraJ,WijewickramaA,SeneviratneSL, 2010.Dengue viral infections,Indian J Dermatol 55 68 -78
UbolS,PhukliaW,KalayanaroojS,ModhiranN, 2010.Mechanism of immune evasion induced by a complex of dengue virus and pre-existing enhancing antibodies,J Infect Dis 201 923 -35
BrasierAR,JuH,GarciaJ,SprattHM,VictorSS,ForsheyBM, 2012.A three-component biomarker panel for prediction of dengue hemorrhagic fever,Am J Med Hyg 86 341 -8
BrooksDG,TrifiloMJ,EdelmannKH,TeytonL,McGavernDB,OldstoneMB, 2006.Interleukin-10 determines viral clearance or persistence in vivo,Nat Med 12 1301 -9
SierraB,PerezAB,VogtK,GarciaG,SchmolkeK,AguirreE, 2010.Secondary heterologous dengue infection risk: disequilibrium between immune regulation and inflammation?,Cell Immunol 262 134 -40
PerezAB,SierraB,GarciaG,AguirreE,BabelN,AlvarezM, 2010.Tumor necrosis factor-alpha, transforming growth factor-β‚ 1 and interleukin-10 gene polymorphism: implication in protection or susceptibility to dengue,Hum Immunol 71 1135 -40
0

Citations

0

Downloads

53

Views